WallStreetZenWallStreetZen

NASDAQ: TPST
Tempest Therapeutics Inc Stock Ownership - Who owns Tempest Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tempest Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Versant Venture Capital VI LP10% Owner2024-08-12387,999$1.10
$427.19kSell
Versant Venture Capital VI LP10% Owner2024-08-08400,000$1.35
$540.00kSell
Stephen R. BradyPresident and CEO2024-07-0335,000$2.11
$73.85kBuy
Samuel WhitingChief Medical Officer2024-07-024,672$2.13
$9.95kBuy
Justin TrojanowskiCorporate Controller2024-06-287,500$2.16
$16.20kBuy

1 of 1

TPST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TPST insiders and whales buy or sell their stock.

TPST Shareholders

What type of owners hold Tempest Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michelle Dipp216.14%7,959,182$52.61MInsider
Richard Aldrich141.61%5,214,762$34.47MInsider
Christoph H. Westphal122.94%4,527,348$29.93MInsider
Versant Venture Capital VI LP95.24%3,507,056$23.18MInsider
Versant Venture Management LLC95.24%3,507,055$23.18MInstitution
Bessemer Venture Partners VII LP64.96%2,392,034$15.81MInsider
Thomas Woiwode59.30%2,183,788$14.43MInsider
Versant Vantage II LP57.53%2,118,644$14.00MInsider
Longwood Fund LP49.96%1,839,689$12.16MInsider
New Enterprise Associates 15 LP47.97%1,766,407$11.68MInsider

1 of 3

TPST vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TPST10.61%89.39%Net Selling
PASG43.94%56.06%Net SellingNet Selling
NNVC2.76%97.24%
CALC13.56%86.44%Net BuyingNet Buying
GDTC0.27%57.45%
View Top Biotech Stocks

Tempest Therapeutics Stock Ownership FAQ

Who owns Tempest Therapeutics?

Tempest Therapeutics (NASDAQ: TPST) is owned by 162.60% institutional shareholders, 1,370.48% Tempest Therapeutics insiders, and 0.00% retail investors. Michelle Dipp is the largest individual Tempest Therapeutics shareholder, owning 7.96M shares representing 216.14% of the company. Michelle Dipp's Tempest Therapeutics shares are currently valued at $52.61M.

If you're new to stock investing, here's how to buy Tempest Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.